The Ten Most Common Questions on Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Patients
Abstract With the rising number of patients undergoing hematopoietic stem cell transplantation (HSCT), clinicians are more likely to encounter infectious complications in immunocompromised hosts, particularly cytomegalovirus (CMV) infection. Besides the high mortality of CMV end-organ disease, patie...
Main Authors: | Johnny Zakhour, Fatima Allaw, Sara F. Haddad, Souha S. Kanj |
---|---|
Format: | Article |
Language: | English |
Published: |
SAABRON PRESS
2022-12-01
|
Series: | Clinical Hematology International |
Subjects: | |
Online Access: | https://doi.org/10.1007/s44228-022-00025-3 |
Similar Items
-
Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01) -
The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
by: Masoud Mardani, et al.
Published: (2020-12-01) -
Cytomegalovirus infection in transplant recipients
by: Luiz Sergio Azevedo, et al.
Published: (2015-07-01) -
Comparison of prophylactic versus preemptive treatments in the management of cytomegalovirus infection in renal transplant recipients
by: Cengiz Karaçin, et al.
Published: (2020-05-01) -
Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients
by: Jhong-Lin Wu, et al.
Published: (2017-06-01)